FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77509
News■ Unclear/unknown
Med Tech Solutions Unifies Stoltenberg Consulting and Avarion Under the MTS Brand
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Brand consolidation of healthcare IT consultancies signals continued services roll-up activity.
Private rebrand, no financial detail
CATALYST TO WATCH
Client or contract announcements
MAIN RISK
Private firm, no tradable exposure
FULL DISPATCH
Brand evolution brings MTS' expanded acute care capabilities together under one unified healthcare technology partner VALENCIA, Calif., Oct. 13, 2026/PRNewswire/ -- Med Tech Solutions (MTS) today announced the next step in the evolution of its organization, with the Stoltenberg Consulting...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
CONTEXTHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
NextPlat Opens New Jacksonville Pharmacy Location to Offer High-Value Services for Patients and Local Healthcare Providers2026-10-13 12:01 UTC
NextPlat Opens New Jacksonville Pharmacy Location to Offer High-Value Services for Patients and Local Healthcare Providers2026-10-13 12:01 UTC
→CORRELATIONshares Healthcare
symplr's Compass Survey Finds Nearly Half of Healthcare Operations Remain Manual2026-10-13 12:05 UTC
symplr's Compass Survey Finds Nearly Half of Healthcare Operations Remain Manual2026-10-13 12:05 UTC
→CORRELATIONshares Healthcare
Prosper AI Report Finds $108 Billion Annual Revenue Opportunity for U.S. Specialty Practices2026-10-13 12:05 UTC
Prosper AI Report Finds $108 Billion Annual Revenue Opportunity for U.S. Specialty Practices2026-10-13 12:05 UTC
→CORRELATIONshares Healthcare
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 20262026-10-13 12:05 UTC
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 20262026-10-13 12:05 UTC
→CORRELATIONshares Healthcare
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones2026-10-13 12:30 UTC
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones2026-10-13 12:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.